Treatment of Atrophic Nonunion by Preosteoblast Cells
Treatment of Refractory Non-union Fractures by Pre-osteoblast Cells Grafting : a Pilot Study.
1 other identifier
interventional
30
1 country
1
Brief Summary
Treatment of nonunion, delayed union and malunion fractures of long bones remains problematic. The definition of nonunion is a failure of the fracture to heal in six months in a patient in whom progressive repair had not been observed radiographically between the third and sixth month after the fracture. First of all good surgical techniques are stable immobilization must be obtained and local sepsis excluded. Then stimulation of the callus is required. Numerous techniques have been developed ranging from invasive interventions (including internal fixation with the use of bone graft or bone graft substitutes) to non invasive procedures (ultrasound and pulsed electromagnetic fields). Recently, autologous cell therapy was presented as an interesting approach. The concept of such therapies is based on the effect of stem cells presented in the bone marrow and able to be transformed in osteoblast cells. The percutaneous technique of autologous bone-marrow grafting is a minimally invasive alternative able to produce a good healing of the fracture. The efficacy is dependent of the concentration in progenitor cell reinjected. An optimization of this type of treatment could be achieved using a technique to increase the differentiation of the bone marrow cells in preosteoblasts before the injection in situ by an adequate culture. Therefore we would like to start a pilot open study on the feasibility and the efficacy of implantation of preosteoblasts into nonunion. Two different presentations exist: the atrophic and the hypertrophic pseudarthrosis in relationship with radiological features of bone proliferation at the tip of bone fragments. Some data support that atrophic and hypertrophic nonunion fractures could have different physiopathological factors. So, in a first time we only would evaluate the atrophic form and to determine in an open study the effect of the implantation of preosteoblasts into atrophic nonunion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Nov 2008
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 3, 2009
CompletedFirst Posted
Study publicly available on registry
June 10, 2009
CompletedFebruary 23, 2012
February 1, 2012
7 months
June 3, 2009
February 22, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
radiological progression of bone fusion
monthly
1, 2, 3, 4, 5, 6 months
Secondary Outcomes (1)
reduction of pain using VAS
each month
Interventions
percutaneously injection of preosteoblast into the nonunion under radioscopic control
Eligibility Criteria
You may qualify if:
- Fracture of a long bone having insufficient healing after minimum 6 months.
- Be able and willing to participate in the study.
You may not qualify if:
- Evidence of malignant disorder in the past five year.
- Patient who is positive for an HIV, hepatitis B or C infection.
- Insufficient reduction of the fracture with displaced fragments.
- Evidence of local sepsis by biological parameters and/or positive isotopic scan using leucocytes labelled by Indium.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Sart Tilman
Liège, Liège, 4000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Philippe Hauzeur, MD, PhD
University of Liège, Belgium
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 3, 2009
First Posted
June 10, 2009
Study Start
November 1, 2008
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
February 23, 2012
Record last verified: 2012-02